Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Apr;60(4):355-60.
doi: 10.1136/jcp.2006.040030. Epub 2006 Oct 3.

Ovarian clear cell adenocarcinoma: a continuing enigma

David S P Tan  1 , Stan Kaye
Affiliations
Review

Ovarian clear cell adenocarcinoma: a continuing enigma

David S P Tan et al. J Clin Pathol. 2007 Apr.

Abstract

Ovarian clear cell adenocarcinomas (OCCAs) account for <5% of all ovarian malignancies. Compared to other epithelial ovarian cancer (EOC) subtypes, when at an advanced stage, they are associated with a poorer prognosis and are relatively resistant to conventional platinum-based chemotherapy. By contrast, early-stage clear cell ovarian cancer carries a relatively good prognosis. Hence, there is a need to improve our understanding of its pathobiology in order to optimise currently available treatments and develop new therapeutic strategies. This review summarises the currently available literature regarding the pathogenesis of OCCA, its molecular genetic features and postulated molecular mechanisms that underlie its chemoresistant phenotype. Marked similarities with clear cell carcinomas of the kidney and endometrium have been noted by some investigators, raising interesting possibilities regarding novel therapeutic approaches. Unfortunately, most studies on OCCA have hitherto been hampered by insufficient sample sizes, leaving many key issues unresolved. It is envisaged that in the future, high-resolution genomic and gene-expression microarray studies incorporating larger sample sizes will lead to the characterisation of the key molecular players in OCCA biology, which may potentially lead to the identification of novel targets for therapeutic development.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aure J C, Hoeg K, Kolstad P. Mesonephroid tumors of the ovary. Clinical and histopathologic studies. Obstet Gynecol 197137860–867. - PubMed
    1. Crozier M A, Copeland L J, Silva E G.et al Clear cell carcinoma of the ovary: a study of 59 cases. Gynecol Oncol 198935199–203. - PubMed
    1. Kennedy A W, Biscotti C V, Hart W R.et al Ovarian clear cell adenocarcinoma. Gynecol Oncol 198932342–349. - PubMed
    1. O'Brien M E, Schofield J B, Tan S.et al Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol 199349250–254. - PubMed
    1. Sugiyama T, Kamura T, Kigawa J.et al Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum‐based chemotherapy. Cancer 2000882584–2589. - PubMed

MeSH terms